These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9225009)

  • 1. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
    J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
    Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
    J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J; Olek S; Fleischer B; von Bonin A
    Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
    Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
    Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of adenosine deaminase to the lymphocyte surface via CD26.
    De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
    Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
    Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
    Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
    Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
    Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
    Martín M; Huguet J; Centelles JJ; Franco R
    J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent measurement of adenosine deaminase and dipeptidyl peptidase IV activity in the diagnosis of tuberculous pleural effusion.
    Küpeli E; Karnak D; Elgün S; Argüder E; Kayacan O
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):365-71. PubMed ID: 19762195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status.
    Ruiz P; Nassiri M; Steele B; Viciana AL
    Cytometry; 1996 Apr; 23(4):322-9. PubMed ID: 8900475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD; Castellazzi M; Buttin G
    J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
    Bopp A; De Bona KS; Bellé LP; Moresco RN; Moretto MB
    Fundam Clin Pharmacol; 2009 Aug; 23(4):501-7. PubMed ID: 19709327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
    Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M
    J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
    van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
    Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of potent 3- or 4-substituted-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
    Fukushima H; Hiratate A; Takahashi M; Saito M; Munetomo E; Kitano K; Saito H; Takaoka Y; Yamamoto K
    Bioorg Med Chem; 2004 Dec; 12(23):6053-61. PubMed ID: 15519151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes.
    Cordero OJ; Salgado FJ; Fernández-Alonso CM; Herrera C; Lluis C; Franco R; Nogueira M
    J Leukoc Biol; 2001 Dec; 70(6):920-30. PubMed ID: 11739555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
    Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
    Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
    Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
    J Immunol; 1997 Apr; 158(8):3721-9. PubMed ID: 9103436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.